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Summary
Introduction: The Hip disability and Osteoarthritis Outcome Score (HOOS) was constructed in Sweden; this questionnaire has proved to be
valid for persons with hip disability with or without hip osteoarthritis (OA) and with high demands of physical function.
Objective: The objective of this study was to evaluate the internal consistency, reliability, construct validity, and ﬂoor and ceiling effects of the
Dutch version of the HOOS questionnaire.
Patients and methods: After translation with a forward/backward protocol, 74 hip arthroplasty patients and 88 hip OA patients ﬁlled in the
Dutch HOOS, as well as a Short Form-36 (SF-36), an Oxford Hip Score (OHS) and a VAS-pain questionnaire.
Results: The Dutch version of the HOOS questionnaire achieved excellent scores in all of the clinimetric properties.
Conclusion: The Dutch HOOS questionnaire has a good internal consistency and reliability. Moreover, the construct validity is good and no
ﬂoor and ceiling effects were found. The HOOS is a good instrument for patients with different stadia of hip OA.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The Western Ontario and McMaster Universities Osteoarthri-
tis Index (WOMAC) is a widely used, patient-administered
and disease-speciﬁc instrument used by older patients1,2. In
1988 it was validated for patients with osteoarthritis (OA) of
the hip or the knee2. The WOMAC is recommended by the
Osteoarthritis Research Society for use in clinical trials in
people with hip OA to measure pain and disabilities3. How-
ever, because the WOMAC does not evaluate the whole do-
main of patient-relevant outcome in young and active
patients, it was extended, to improve its validity for those
with high demands of physical function. Dimensions concern-
ing sport and recreation and hip-related Quality of Life were
added to theWOMACand thus theHip disability andOsteoar-
thritis Outcome Score (HOOS) was constructed in Sweden4.
The Swedish version of the HOOS has been validated for
use in patients with hip disability with or without hipOA in sec-
ondary care and is considered to be useful for the evaluation
of patient-relevant outcomes in patients after a total hip re-
placement (THR)5. The content validity was ensured through
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Received 3 April 2006; revision accepted 25 June 2006.10a literature search involving interviews with more than 100
patients with hip disability6 and by questioning 90 patients
undergoing THR5. A high testeretest reliability was found
(intraclass correlation coefﬁcients: ICCs 0.78e0.91) for all
subscales of theHOOS6. For the construct validity Spearman
correlations of 0.49e0.66 were found between the HOOS
subscales and the Short Form-36 (SF-36) subscales5.
After a systematic review of the literature on psychometric
evaluation of OA questionnaires Veenhof et al. reported that
the HOOS questionnaire was one of the top three question-
naires with the best ratings for its descriptive and psychometric
qualities to evaluate bothpain andphysical functions7. Further-
more, Veenhof et al. concluded that the HOOS has not been
studied extensively and that its rating would probably improve
if more studies were conducted on its psychometric qualities7.
The purpose of this study was to translate the HOOS into
Dutch and to evaluate the clinimetric quality of the Dutch
version of the HOOS as expressed by internal consistency,
reliability, construct validity, and ﬂoor and ceiling effects in
patients with OA of the hip in primary care and in patients
with a THR in secondary care.
Methods
The study was divided into two stages: ﬁrst, the Swedish
version of the HOOS was translated into Dutch according to
a standardized procedure described by Beaton et al.8, and4
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PROCEDURE OF TRANSLATION
The procedure of translation included three steps8. Firstly
two persons (T1 and T2) translated independent of each
other the Swedish version of the HOOS into Dutch (forward
translation); one translator had a technical background and
the other had a medical background but both were native
speakers. Based on a consensus meeting one ﬁnal version
(T-12) was formed.
Secondly, two bilingual persons (T3 and T4), one with
a background in education and the other with a chemical
background but both native Swedish speakers, indepen-
dently re-translated this Dutch version (T-12) into Swedish
(backward translation). They were blind to the original
Swedish version.
Eventually all translators had a consensus meeting to
consolidate the ﬁnal version of the Dutch version of the
HOOS which was used in the present study. This ﬁnal ver-
sion was presented to a subset of 15 patients. These pa-
tients were asked whether they understood all items and
whether they had problems with the formulation of the items
of the Dutch version of the HOOS. None of the patients re-
ported problems with the items of the HOOS.
PATIENTS
Two study populations with mild to moderate and severe
OA participated in this study to evaluate the Dutch version
of the HOOS. The ﬁrst group consisted of a random selection
of patients with hip OA who participated in the Glucosamine
sulphate OsteoArthritis Long-term efﬁcacy study9. These pa-
tients were recruited from general practitioners in the Rotter-
dam area, and were included in the study when they met one
of the American College of Rheumatology criteria for hip OA.
Patients who had already undergone THR or those on the
waiting list for THR were not included in the study; nor were
patients with a Kellgren & Lawrence score of grade 49.
The second study population consisted of patients who
had undergone THR because of primary or secondary OA
at the Department of Orthopaedics (Erasmus Medical Cen-
tre, Rotterdam). Mean duration after THR was 9.5 months
(SD 3.7). Of the patients who had undergone THR between
September 2003 and October 2004, 87 were invited to par-
ticipate in the present study. Patients unable to understand
Dutch written language were excluded. The study was ap-
proved by the Medical Ethics Committee of the Erasmus
Medical Centre.
Participants were asked to ﬁll in four questionnaires at
home, namely the Dutch HOOS, the SF-3610, the Oxford
Hip Score (OHS)11 and a visual analogue scale (VAS) for
pain12. For testeretest studies the time interval needs to be
sufﬁciently short to support the assumption that the patients
remainstable, andsufﬁciently long toprevent recall13; a retest
interval of 2e14 days is usual14. We considered a time inter-
val of 3 weeks to be appropriate for the current population.
Questionnaires
HOOS
The HOOS includes ﬁve subscales: Pain, other Symp-
toms, Function in Daily living (ADL), Function in Sport and
Recreation (Sport/Rec), and hip-related Quality of Life(QoL). Standardized response options are given (5-point
Likert scale) and each question is scored from 0 to 4;
then a normalized score (100 indicating no symptoms and
0 indicating extreme symptoms) is calculated for each sub-
scale. The user’s guide can be downloaded from
www.koos.nu. The format is user-friendly and takes about
10 min to ﬁll in. HOOS is self-explanatory and can be ad-
ministered in the waiting room or used as a mailed survey5.
SF-36
The SF-36 is a generic health status questionnaire which
contains 36 items. It measures eight major attributes (bodily
pain; physical function; social function; role limitations be-
cause of physical problems; role limitations because of
emotional problems; mental health; vitality; general health
perceptions)15. It is widely used, reliable and validated
into Dutch, and is easy to ﬁll in10.
OXFORD HIP SCORE
The OHS is a disease-speciﬁc questionnaire consisting
of 12 questions assessing pain and function of the hip in
relation to different activities of daily life. Standardized re-
sponse options were given (5-point Likert scale) and each
question was scored from 1 to 5; then a summary score
(12 indicating no difﬁculties symptoms and 60 indicating
most difﬁculties) was calculated. The OHS was developed
speciﬁcally to assess outcomes of hip arthroplasty and
has shown to be consistent, reliable, valid and sensitive to
clinical change16. The Dutch OHS has shown to be valid
and reliable in measuring outcome in THR patients11.
VAS FOR PAIN
The VAS for pain is a simple way of measuring the inten-
sity of pain. The 100-mm VAS is a uni-dimensional scale
and it is considered to be valid and reliable12.
STATISTICAL ANALYSIS
Hypotheses were formulated about the expected magni-
tude and direction of relationships between (subscales of)
the HOOS and the other instruments (see Table I). We de-
ﬁned the construct validity of the HOOS as good if 75% of
the hypotheses could be conﬁrmed17. Data were analysed
with SPSS statistical software version 10.1. The level of sig-
niﬁcance for all statistical procedures was P 0.05.
Internal consistency
A high degree of homogeneity is desirable in a scale. This
has two implications: (1) the items should be moderately
correlated with each other, and (2) each should correlate
with the total scale score14. These two factors form the
basis of the various tests of homogeneity or internal consis-
tency of the scale. The internal consistency was determined
by calculating the Cronbach’s alpha. The widely-accepted
social science cut-off is that Cronbach’s alpha should
be 0.70 or higher for a set of items to be considered a
(sub)scale14,18.
Reliability
Reliability concerns the degree towhich the results ofmea-
surement are consistent across repeated measurements14.
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ICCs (two-way mixed effects model absolute agreement)
with 95% conﬁdence interval (95% CI) were calculated.
The ICC is generally considered to be good at 0.70 and
above14. The standard error of measurement (S.E.M.) is the
variability in measurements of the same individual and is
expressed in the dimension of the measurement. The S.E.M.
is calculated as the square root of the sum of the between
measures variance and the residual variance19.
Validity
Validity is the degree to which an instrument measures
the construct it is intended to measure. Because of the
absence of a gold standard, construct validity was
Table I
Hypotheses and the confirmation or rejection of the hypotheses for
hip OA and THR group
HIP OA THR
1. A correlation of at least 0.5 between the HOOS subscale pain
and the SF-36 subscale bodily pain.
yes yes
2. A correlation of at least 0.5 between the HOOS subscale pain
and the SF-36 subscale physical function.
yes yes
3. The correlation between the HOOS subscale ADL and the SF-36
subscale physical function’’ is higher than the correlation between
the HOOS subscale sport/recreation and the SF-36 subscale phys-
ical function.
yes yes
4. The correlation between the HOOS subscale pain and the SF-36
subscale bodily pain should be at least 0.1 higher than the correla-
tion between the HOOS subscale pain and the other subscales of
the SF-36.
yes yes
5. The correlation between the HOOS subscale ADL and the SF-36
physical function should be at least 0.1 higher than the correlation
between the HOOS subscale ADL and the other subscales of the
SF-36.
no no
6. The correlation between the HOOS subscale sport/recreation
and the SF-36 subscale physical function should be at least 0.1
higher than the correlation between the HOOS subscale sport/rec-
reation and the other subscales of the SF-36.
no no
7. A correlation of at least 0.5 between all the subscales of the
HOOS and the OHS.
yes yes
8. A correlation of at least 0.5 between the HOOS subscale pain
and the VAS for pain.
yes yes
75.0% conﬁrmed 75.0% conﬁrmedexamined. Construct validity is concerned with the extent
to which a particular measure relates to other measures
consistent with theoretically derived hypotheses for the
constructs that are being measured14. The construct
validity of the HOOS was determined by comparing its
results with the generic SF-36, the OHS and the VAS
for pain. To evaluate the construct validity of the Dutch
HOOS version, Pearson’s correlation coefﬁcients were
calculated.
Floor and ceiling effects
The presence of ﬂoor and ceiling effects may inﬂuence
the reliability, validity and responsiveness of an instrument.
An intervention effect might be missed for people who oc-
cupy the maximum score14. Floor and ceiling effects were
considered present if more than 15% of the respondents
achieved the highest or lowest possible score20.
Results
Table II presents the baseline characteristics of the two
study groups. The ﬁrst group consisted of patients with
hip OA. For the testeretest reliability 65 patients were
asked to ﬁll in the HOOS questionnaire twice, of which 49
patients replied (response rate of 75%). For the cross-sec-
tional validity 50 other hip OA patients were asked to ﬁll in
the HOOS questionnaire, the SF-36, the OHS and the
VAS for pain. Thirty-nine patients replied these question-
naires for the cross-sectional validity (response rate of
78%). The second group consisted of patients with a THR.
Eighty-ﬁve patients were asked to ﬁll the questionnaires
for both the cross-sectional validity and the testeretest reli-
ability. Seventy-four patients ﬁlled in the questionnaires for
the cross-sectional validity (response rate of 87%). Of these
74 patients, 68 patients ﬁlled in the HOOS questionnaire
twice for the testeretest reliability. No differences were
found in the THR group and the hip OA group concerning
age (P-value of 0.97 and 0.32, respectively) and gender
(P-value of 0.95 and 0.69, respectively) between the
responders and non-responders.
INTERNAL CONSISTENCY
Table III presents the internal consistency expressed by
Cronbach’s alpha. For each HOOS subscale Cronbach’s
alpha was above 0.70 in both groups, indicating a sufﬁcient
homogeneity of all items in the (sub)scale.
RELIABILITY
Table IV shows the ICC of all subscales of the HOOS for
the two study groups. The HOOS questionnaire was com-
pleted within 7.6 days, range 3e20 days. For all subscalesTable II










Age in years, median (range) 68.0 (48e80) 66.0 (50e79) 63.1 (31e88) 64.5 (31e88)
Gender, women % 63.3 66.7 67.6 67.6
OA: mildemoderate (%) 49e51 46e54
Mild: Kellgren & Lawrence score of grade 1. Moderate: Kellgren & Lawrence score of grades 2e3.
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groups, indicating a good testeretest reliability.
VALIDITY
The correlations between the HOOS subscales, the
SF-36 subscales, the OHS and the VAS for pain are pre-
sented in Table V.
The highest correlations between the HOOS and the
SF-36 were found for the subscales which intended to mea-
sure similar constructs (pain vs bodily pain, r¼ 0.76/0.75;
ADL vs physical function, r¼ 0.68/0.72; Sport/Rec vs phys-
ical function, r¼ 0.58/0.59). Correlations between the
HOOS subscales and the OHS were between r¼0.62
and 0.88. Correlations between the HOOS subscale
Pain and the VAS-pain were between r¼0.76 and
0.68. Of the eight predeﬁned hypotheses about construct
validity, 75% could be conﬁrmed (see Table I).
FLOOR AND CEILING EFFECTS
No patient reported the worst or best possible score
(ﬂoor/ceiling effect) in the HOOS subscales Pain, Symp-
toms, ADL and QoL. Floor effects (indicating worst possible
score) were found only in the subscale Sport/Rec in 5.1% in
the hip OA group and in 4.1% in the THR group. No ceiling
effects were found in either of the two groups.
DISCUSSION
Based on the results of this validation study of the Dutch
version of the HOOS, we consider the HOOS to be an inter-
nally consistent, reliable and valid questionnaire (without
ﬂoor and ceiling effects), for patients with hip OA or a THR.
Table III
Internal consistency of the HOOS subscales, expressed by Cron-
bach’s alpha
Subscales HOOS Hip OA (n¼ 39) THR (n¼ 74)
Pain (10 items) 0.74 0.76
Symptoms (ﬁve items) 0.95 0.94
ADL (17 items) 0.98 0.95
Sport/Rec (four items) 0.91 0.80
QoL (four items) 0.75 0.86
Abbreviations: ADL, function in daily living; QoL, hip-related
quality of life.In a study on hip pain patients without operation, Klassbo
et al. reported the highest Cronbach’s alpha for the
subscale ADL and the lowest Cronbach’s alpha for the
subscale QoL6. In the present study the highest Cronbach’s
alpha was also found for the subscale ADL. The lowest
Cronbach’s alpha in our study was found for the subscale
Pain, which was still considered good (present study vs
the study of Klassbo et al.: Pain 0.76 vs 0.93, Symptoms
0.94 vs 0.82, ADL 0.95 vs 0.96, Sport/Rec 0.80 vs 0.88
and QoL 0.86 vs 0.77). In the present study some Cronba-
ch’s alphas were above 0.90; this means that some of the
items of the HOOS questionnaire could have been removed
because they may be redundant. Klassbo et al. reported
that they could have removed some WOMAC items to
form a shorter questionnaire; however, they decided to
keep all WOMAC items in the HOOS because of the world-
wide use of the WOMAC and also because of the possibility
to calculate scores for both instruments. Moreover, they
could ensure validity for elderly people and also for later
stages of hip OA6.
Klassbo et al. validated the Swedish HOOS question-
naire in patients with hip pain without operation of the hip
and found a good testeretest reliability (ICC 0.78e0.98)6.
Our results of the testeretest reliability were similar to that
of Klassbo et al. (ICC 0.75e0.97). Based on the results of
these two studies we conclude that the HOOS is a reliable
questionnaire.
To determine whether the test is measuring what was
intended to measure requires evidence of validity. Because
of the absence of a gold standard, the construct validity was
assessed. Correlations between constructs which measure
the same constructs were examined. In our study we found
the highest correlations between the HOOS subscales
and the SF-36 subscales which are intended to measure
the same constructs, similar to the study of Nilsdotter
et al. (THR population)5. Compared to the study of Nilsdot-
ter et al. we found higher correlations (present study vs
study of Nilsdotter et al.: ADL vs PF r¼ 0.72 vs 0.66,
Sport/Rec vs PF r¼ 0.59 vs 0.49 and Pain vs BP r¼ 0.75
vs 0.61)5. The population in the study of Nilsdotter et al.
was older (mean age 71.5, range 49e85 years) compared
to our THR population (mean age 62.5, range 31e88 years).
In a study comparing the epidemiology of THR in the Nether-
lands and SwedenOstendorf et al. reported that the Swedish
THR population is generally older compared to the Dutch
population21. We also compared the HOOS questionnaireTable IV
Descriptive statistics and testeretest reliability of the HOOS
Baseline mean (SD) Retest mean (SD) Change scores
mean (SD)
S.E.M. ICC agreement 95% CI
Hip OA (n¼ 49)
Pain 51.7 (18.8) 49.3 (21.2) 1.2 (9.8) 6.94 0.88 0.80e0.93
Symptoms 50.7 (20.1) 50.2 (21.9) 0.1(5.4) 3.77 0.97 0.94e0.98
ADL 51.9 (19.5) 48.5 (21.5) 2.2 (7.0) 5.16 0.94 0.89e0.96
Sport/Rec 38.9 (27.7) 34.9 (27.0) 1.7 (8.1) 5.77 0.96 0.92e0.98
QoL 43.5 (21.5) 42.8 (22.6) 0.4 (5.3) 3.71 0.97 0.95e0.98
THR (n¼ 68)
Pain 64.2 (15.3) 65.4 (14.3) 0.9 (7.0) 4.97 0.89 0.82e0.93
Symptoms 59.3 (16.6) 60.1 (14.6) 1.1 (9.2) 6.49 0.82 0.73e0.89
ADL 60.7 (15.9) 62.3 (14.5) 1.4 (6.7) 4.78 0.90 0.84e0.94
Sport/Rec 43.7 (20.4) 47.2 (20.8) 3.2 (14.0) 10.07 0.76 0.64e0.85
QoL 40.0 (14.1) 42.8 (14.1) 2.6 (9.7) 7.03 0.75 0.62e0.84
Abbreviations: SD, standard deviation; S.E.M., standard error of measurement; ICC agreement, intraclass correlation coefﬁcient for agree-
ment; CI, conﬁdence interval. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each
subscale.
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Validity of the HOOS expressed by Pearson correlations between HOOS subscales and SF-36 subscales, Oxford hip scale and VAS-pain for
hip OA (n¼ 39)/THR (n¼ 74)
HOOS
Pain Symptoms ADL Sport/Rec QOL
SF-36 subscale
BP 0.76/0.75 0.57/0.48 0.78/0.65 0.63/0.64 0.65/0.53
PF 0.63/0.59 0.56/0.46 0.68/0.72 0.58/0.59 0.47/0.43
SF 0.48/0.34 0.38/0.30 0.46/0.46 0.36/0.40 0.41/0.15
RF 0.49/0.56 0.38/0.49 0.52/0.67 0.55/0.56 0.41/0.41
RE 0.29/0.38 0.18/0.24 0.38/0.43 0.38/0.20 0.14/0.13
MH 0.06/0.25 0.09/0.25 0.10/0.42 0.17/0.23 0.12/0.13
VT 0.11/0.30 0.14/0.28 0.10/0.34 0.13/0.24 0.08/0.16
GH 0.33/0.23 0.13/0.04 0.35/0.28 0.31/0.23 0.10/0.02
Oxford 0.83/0.85 0.71/0.70 0.88/0.85 0.74/0.69 0.66/0.62
VAS for pain 0.76/0.68 0.06/0.51 0.73/0.56 0.68/0.49 0.58/0.42
Abbreviations: BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical problems; RE, role
limitations because of emotional problems; MH, mental health; VT, vitality; GH, general health perception.with the Dutch version of the OHS; all correlations be-
tween HOOS subscales and the OHS were above 0.60.
Based on these results we conclude that the HOOS is
a valid questionnaire for patients with a THR and for
those with hip OA.
The strength of the present study is that we used two differ-
ent study groups with different stages of hip OA. Besides, we
used two questionnaires to evaluate the construct validity of
theDutchversionof theHOOS, i.e., ageneral healthquestion-
naire (SF-36) and a disease-speciﬁc questionnaire (OHS).
A measurement tool can also be used to monitor the ef-
ﬁcacy of an intervention or the disease process of the pa-
tient. For this goal the tool needs to be sensitive to detect
clinically relevant changes during a certain period (respon-
siveness), therefore the responsiveness of the HOOS
needs to be evaluated in a future study.
Conclusion
We conclude that the Dutch HOOS questionnaire has
a good internal consistency and reliability. Moreover, 75%
of the predeﬁned hypotheses about construct validity could
be conﬁrmed and we therefore conclude that the construct
validity of the HOOS questionnaire is also good. No ﬂoor
and ceiling effects were found. The HOOS is a good instru-
ment for patients with different stadia of hip OA.
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